Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: A randomized, placebo-controlled, double-blind study
Authors:
- Mitchell L. JonesMJMitchell L. Jones
- Christopher J. MartoniCMChristopher J. Martoni
- Sandeep TamberSTSandeep Tamber
- Mathieu ParentMPMathieu Parent
- Satya PrakashSatya Prakash
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 50 (6) , 2216-2223
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: A randomized, placebo-controlled, double-blind studyFood and Chemical Toxicology, 2011
- Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study)The American Journal of Cardiology, 2011
- Is microencapsulation the future of probiotic preparations? The increased efficacy of gastro-protected probioticsGut Microbes, 2011
- Lactobacillus reuteri (DSM 17938) in Infants with Functional Chronic Constipation: A Double-Blind, Randomized, Placebo-Controlled StudyThe Journal of Pediatrics, 2010
- Trends in hypercholesterolemia, treatment and control among United States adultsInternational Journal of Cardiology, 2010
- Evolution of the Probiotic Concept2010
- Scientific Opinion on the maintenance of the list of QPS microorganisms intentionally added to food or feed (2009 update)EFSA Journal, 2009
- Safety of D(‐)‐Lactic Acid Producing Bacteria in the Human InfantJournal of Pediatric Gastroenterology and Nutrition, 2005
- Simultaneous quantitation of fatty acids, sterols and bile acids in human stool by capillary gas–liquid chromatographyJournal of Chromatography B, 2002
- Validation of the Probiotic Concept: Lactobacillus reuteri Confers Broad-spectrum Protection against Disease in Humans and AnimalsMicrobial Ecology in Health and Disease, 2000